Unituxin, also known as dinutuximab, is a medication used in the treatment of high-risk neuroblastoma, a type of cancer that primarily affects children. This drug is a monoclonal antibody that works by targeting a specific protein found on neuroblastoma cells, helping the body’s immune system to recognize and attack these cancerous cells.

Unituxin is typically administered intravenously in a hospital or clinic setting, and is often given in combination with other chemotherapy drugs and treatments. It is important to follow your healthcare provider’s instructions carefully when receiving Unituxin, as it can cause side effects such as pain, fever, low blood pressure, and allergic reactions.

As a medical professional, I recommend discussing any concerns or questions you may have about Unituxin with your healthcare team. They can provide you with more information about the drug, its potential benefits, and any possible side effects. It is important to weigh the risks and benefits of treatment with Unituxin in order to make an informed decision about your care.

Overall, Unituxin has shown promise in improving outcomes for children with high-risk neuroblastoma, and continues to be an important part of treatment for this challenging disease. By working closely with your healthcare team and staying informed about your treatment plan, you can help ensure the best possible outcome in your fight against neuroblastoma.